{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T14:03:57Z","timestamp":1773497037269,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartandlung.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart & Lung"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.hrtlng.2023.01.008","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T09:55:42Z","timestamp":1674122142000},"page":"8-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Reduced Apela\/APJ system expression in patients with pulmonary artery hypertension secondary to chronic obstructive pulmonary disease"],"prefix":"10.1016","volume":"59","author":[{"given":"Yuexin","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yani","family":"Zong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangli","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jue","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2408-9882","authenticated-orcid":false,"given":"Zhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.hrtlng.2023.01.008_bib0001","doi-asserted-by":"crossref","first-page":"163","DOI":"10.31083\/j.rcm.2020.02.597","article-title":"Current and emerging therapeutic approaches to pulmonary hypertension","volume":"21","author":"Bisserier","year":"2020","journal-title":"Rev Cardiovasc Med"},{"issue":"10082","key":"10.1016\/j.hrtlng.2023.01.008_bib0002","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/S0140-6736(17)31222-9","article-title":"Chronic obstructive pulmonary disease","volume":"389","author":"Rabe","year":"2017","journal-title":"Lancet."},{"key":"10.1016\/j.hrtlng.2023.01.008_bib0003","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.healun.2011.11.020","article-title":"Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease","volume":"31","author":"Andersen","year":"2012","journal-title":"J HeartLung Transplant"},{"key":"10.1016\/j.hrtlng.2023.01.008_bib0004","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1164\/rccm.200401-006OC","article-title":"Severe pulmonary hypertension and chronic obstructive pulmonary disease","volume":"172","author":"Chaouat","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"10204","key":"10.1016\/j.hrtlng.2023.01.008_bib0005","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0140-6736(19)30427-1","article-title":"Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"394","author":"Zhou","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.hrtlng.2023.01.008_bib0006","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s12010-019-03012-2","article-title":"Apela Promotes Cardiomyocyte Differentiation from Transgenic Human Embryonic Stem Cell Lines","volume":"189","author":"Wang","year":"2019","journal-title":"Appl Biochem Biotechnol"},{"issue":"9","key":"10.1016\/j.hrtlng.2023.01.008_bib0007","doi-asserted-by":"crossref","first-page":"6472","DOI":"10.1002\/jcp.26492","article-title":"Biological functions of Elabela, a novel endogenous ligand of APJ receptor","volume":"233","author":"Xu","year":"2018","journal-title":"J Cell Physiol"},{"issue":"18","key":"10.1016\/j.hrtlng.2023.01.008_bib0008","doi-asserted-by":"crossref","first-page":"10382","DOI":"10.1111\/jcmm.15651","article-title":"Apela improves cardiac and renal function in mice with acute myocardial infarction","volume":"24","author":"Pan","year":"2020","journal-title":"J Cell Mol Med"},{"issue":"17","key":"10.1016\/j.hrtlng.2023.01.008_bib0009","doi-asserted-by":"crossref","first-page":"8537","DOI":"10.1111\/jcmm.16814","article-title":"Elabela gene therapy promotes angiogenesis after myocardial infarction","volume":"25","author":"Jin","year":"2021","journal-title":"J Cell Mol Med"},{"issue":"7","key":"10.1016\/j.hrtlng.2023.01.008_bib0010","doi-asserted-by":"crossref","first-page":"e22431","DOI":"10.1096\/fj.202200266R","article-title":"Apela gene therapy alleviates pulmonary hypertension in rats","volume":"36","author":"Hu","year":"2022","journal-title":"FASEB J"},{"issue":"5","key":"10.1016\/j.hrtlng.2023.01.008_bib0011","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1164\/rccm.201701-0218PP","article-title":"Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary","volume":"195","author":"Vogelmeier","year":"2017","journal-title":"Am J Respir Crit Care Med."},{"issue":"7","key":"10.1016\/j.hrtlng.2023.01.008_bib0012","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","volume":"23","author":"Rudski","year":"2010","journal-title":"J Am Soc Echocardiogr"},{"issue":"4","key":"10.1016\/j.hrtlng.2023.01.008_bib0013","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"4","key":"10.1016\/j.hrtlng.2023.01.008_bib0014","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/FJC.0000000000000803","article-title":"Essential Role of the ELABELA-APJ Signaling Pathway in Cardiovascular System Development and Diseases","volume":"75","author":"Zhou","year":"2020","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1-2","key":"10.1016\/j.hrtlng.2023.01.008_bib0015","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0378-1119(93)90495-O","article-title":"A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11","volume":"136","author":"O'Dowd","year":"1993","journal-title":"Gene"},{"issue":"2","key":"10.1016\/j.hrtlng.2023.01.008_bib0016","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1006\/bbrc.1998.9489","article-title":"Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor","volume":"251","author":"Tatemoto","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10.1016\/j.hrtlng.2023.01.008_bib0017","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.devcel.2013.11.002","article-title":"ELABELA: a hormone essential for heart development signals via the apelin receptor","volume":"27","author":"Chng","year":"2013","journal-title":"Dev Cell"},{"issue":"6172","key":"10.1016\/j.hrtlng.2023.01.008_bib0018","doi-asserted-by":"crossref","DOI":"10.1126\/science.1248636","article-title":"Toddler: an embryonic signal that promotes cell movement via Apelin receptors","volume":"343","author":"Pauli","year":"2014","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.hrtlng.2023.01.008_bib0019","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/j.2040-4603.2018.tb00012.x","article-title":"Apelinergic System Structure and Function","volume":"8","author":"Shin","year":"2017","journal-title":"Compr Physiol"},{"issue":"1","key":"10.1016\/j.hrtlng.2023.01.008_bib0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/nyas.14123","article-title":"The apelinergic system: a perspective on challenges and opportunities in cardiovascular and metabolic disorders","volume":"1455","author":"Marsault","year":"2019","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"10.1016\/j.hrtlng.2023.01.008_bib0021","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/CIRCULATIONAHA.116.023218","article-title":"Elabela\/Toddler Is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of Its Expression in Pulmonary Arterial Hypertension","volume":"135","author":"Yang","year":"2017","journal-title":"Circulation."},{"key":"10.1016\/j.hrtlng.2023.01.008_bib0022","doi-asserted-by":"crossref","first-page":"8170","DOI":"10.1038\/srep08170","article-title":"Elabela-apelin receptor signaling pathway is functional in mammalian systems","volume":"5","author":"Wang","year":"2015","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.hrtlng.2023.01.008_bib0023","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03957-2020","article-title":"Endothelial cells in the pathogenesis of pulmonary arterial hypertension","volume":"58","author":"Evans","year":"2021","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.hrtlng.2023.01.008_bib0024","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/01.RES.0000021432.70309.28","article-title":"Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation: in vitro analysis","volume":"90","author":"Frid","year":"2002","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.hrtlng.2023.01.008_bib0025","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/CIRCRESAHA.113.301141","article-title":"Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension","volume":"115","author":"Rabinovitch","year":"2014","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.hrtlng.2023.01.008_bib0026","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1164\/rccm.200709-1369PP","article-title":"The cancer paradigm of severe pulmonary arterial hypertension[J]","volume":"178","author":"Rai","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.hrtlng.2023.01.008_bib0027","doi-asserted-by":"crossref","first-page":"L548","DOI":"10.1152\/ajplung.00428.2006","article-title":"Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension","volume":"293","author":"Masri","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"7","key":"10.1016\/j.hrtlng.2023.01.008_bib0028","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.ajpath.2015.03.019","article-title":"Endothelial to Mesenchymal Transition Contributes to Endothelial Dysfunction in Pulmonary Arterial Hypertension","volume":"185","author":"Good","year":"2015","journal-title":"Am J Pathol"},{"issue":"126","key":"10.1016\/j.hrtlng.2023.01.008_bib0029","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1183\/09059180.00004812","article-title":"Pathways in pulmonary arterial hypertension: the future is here","volume":"21","author":"Sitbon","year":"2012","journal-title":"Eur Respir Rev"},{"issue":"2","key":"10.1016\/j.hrtlng.2023.01.008_bib0030","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1161\/CIRCRESAHA.116.306531","article-title":"Thirty Years of Saying NO: Sources, Fate, Actions, and Misfortunes of the Endothelium-Derived Vasodilator Mediator","volume":"119","author":"Vanhoutte","year":"2016","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.hrtlng.2023.01.008_bib0031","doi-asserted-by":"crossref","first-page":"196","DOI":"10.14348\/molcells.2014.2308","article-title":"Apelin-APJ signaling: a potential therapeutic target for pulmonary arterial hypertension","volume":"37","author":"Kim","year":"2014","journal-title":"Mol Cells"},{"issue":"9","key":"10.1016\/j.hrtlng.2023.01.008_bib0032","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1172\/JCI43382","article-title":"Disruption of PPAR\u03b3\/\u03b2-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival","volume":"121","author":"Alastalo","year":"2011","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.hrtlng.2023.01.008_bib0033","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jacbts.2018.01.013","article-title":"Short-Term Hemodynamic Effects of Apelin in Patients With Pulmonary Arterial Hypertension","volume":"3","author":"Brash","year":"2018","journal-title":"JACC Basic Transl Sci"}],"container-title":["Heart & Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956323000080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956323000080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T06:39:45Z","timestamp":1758955185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0147956323000080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":33,"alternative-id":["S0147956323000080"],"URL":"https:\/\/doi.org\/10.1016\/j.hrtlng.2023.01.008","relation":{},"ISSN":["0147-9563"],"issn-type":[{"value":"0147-9563","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced Apela\/APJ system expression in patients with pulmonary artery hypertension secondary to chronic obstructive pulmonary disease","name":"articletitle","label":"Article Title"},{"value":"Heart & Lung","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrtlng.2023.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}